CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.55
−0.44%Forward multiples
Based on analyst estimates
- P/E forward
- 2.74x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.27x
- P/S forward
- 0.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.26x
- Price / sales
- 7.17x
- Price / cash flow
- -2.58x
Enterprise value
- Enterprise value
- $44.6M
- EV / sales
- 6.27x
- EV / EBITDA
- -1.03x
- EV / EBIT
- -0.94x
- Market cap
- $50.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026